The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1573

Jemma Scattergood, Lucy Westwood

引用次数: 0

No universal health coverage without nurses 没有护士就没有全民医保

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1480

Preeti Kumar, Rajna Mishra, Leila Caleb Varkey

{"title":"No universal health coverage without nurses","authors":"Preeti Kumar, Rajna Mishra, Leila Caleb Varkey","doi":"10.1136/bmj.r1480","DOIUrl":"https://doi.org/10.1136/bmj.r1480","url":null,"abstract":"Stem workforce shortages and empower profession to meet 2030 goals Over its long history nursing has evolved from a vocation to a professional discipline with the largest health workforce worldwide. The number of nurses grew from 27.9 million in 2018 to 29.8 million in 2023, but an estimated 5.8 million global shortage persists.1 According to the 2025 report on the state of the world’s nursing from the World Health Organization and the International Council of Nurses (ICN), which represents the profession worldwide, most low and middle income countries are unlikely to meet their goals to achieve universal health coverage and better healthcare outcomes by 2030.1 Action is urgently needed to fill workforce gaps, improve pay and working conditions, minimise the harms of nurse migration, encourage gender balance and reduce the gender pay gap in the profession, and ensure nurses benefit fully from digital innovation. Global differences in workforce numbers are stark: high income countries have more nurses per capita than low and middle income countries. The Americas region, for example, has 72.2 nurses per 10 000 population, compared with 17.4 in the South East Asia region,1 with wide variation among countries: the Philippines has 47.9 and India 17.2. …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Non-prescribed ketamine use is rising in the UK—including among under 16s 在英国，非处方氯胺酮的使用量正在上升，包括16岁以下的人

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1521

Rachel Isba, Liz Brewster, Jude Lunn, Harriet Corbett

引用次数: 0

Advances in the management of osteoporosis 骨质疏松症的治疗进展

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj-2024-081250

Caroline Wei Shan Hoong, Dominik Saul, Sundeep Khosla, Jad G Sfeir

{"title":"Advances in the management of osteoporosis","authors":"Caroline Wei Shan Hoong, Dominik Saul, Sundeep Khosla, Jad G Sfeir","doi":"10.1136/bmj-2024-081250","DOIUrl":"https://doi.org/10.1136/bmj-2024-081250","url":null,"abstract":"Osteoporosis is a chronic disease mainly prevalent in older people. A hip fracture, its most devastating complication, is associated with a one in five chance of mortality in the first year. This review discusses emerging risk factors for bone fragility including diabetes, sarcopenia, and bariatric surgery. Recency of fracture represents an imminent risk that deserves prompt recognition. The new FRAXplus calculator accounts for additional risk factors to refine existing risk stratification. Advances in imaging techniques such as trabecular bone score and radiofrequency echographic multi-spectrometry may have potential roles in specific populations. Treatment of osteoporosis requires a multifaceted approach. Non-drug interventions include fall prevention and resistance exercises, supplementation with calcium, vitamin D and possibly vitamin K, and effective bridging of care gaps with fracture liaison services. An overview of drug therapy is provided, drawing attention to the importance of sequential therapy starting with potent anabolic agents for the patients at the highest risk, as opposed to a traditional step-up approach. An individualized, goal directed care plan is necessary for a treat-to-target approach, with total hip bone mineral density being the best specific target. Future research in cellular senescence points to the role of senolytics and senomorphics to alleviate osteoporosis, among other age related conditions.","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

PAs' union hires Post Office scandal barrister to take on government over Leng review. PAs工会聘请邮政丑闻律师就冷门审查与政府对簿公堂。

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1597

Adele Waters

引用次数: 0

We need a broader perspective on innovations to advance a women and health agenda 我们需要从更广阔的角度看待创新，以推进妇女与健康议程

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1489

Karla Unger Saldaña, Ophira Ginsburg, Ana Langer, Jennifer Moodley

{"title":"We need a broader perspective on innovations to advance a women and health agenda","authors":"Karla Unger Saldaña, Ophira Ginsburg, Ana Langer, Jennifer Moodley","doi":"10.1136/bmj.r1489","DOIUrl":"https://doi.org/10.1136/bmj.r1489","url":null,"abstract":"Although biotech innovations have contributed to improvements in health outcomes, we need more comprehensive health innovation to tackle persistent gender and intersectional equity gaps, argue Karla Unger Saldaña and colleagues Every year millions of women lose their lives to largely preventable conditions such as cardiovascular disease, complications from pregnancy and childbirth, and cervical cancer.1 Technological innovations have contributed to improved health outcomes for women, but their impact has been uneven.2 Technology development for women’s health, also referred to as “femtech,” is on the rise but by itself cannot resolve the root causes of women’s unmet health needs.3 Transformative progress for women globally demands much more. Firstly, health innovation needs to be reimagined beyond purely biological or technological solutions to embrace innovations at the sociocultural, health system, and policy levels. Secondly, women’s needs and context must be foundational to design and implementation of new health technologies. Thirdly, women’s expertise and leadership should be integrated across the innovations ecosystem and technology life cycle, so that women centred health solutions are effective, scalable, and sustainable. Deep rooted patriarchal structures systematically disadvantage women within economic, sociocultural, and political spheres and put their health at …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Obstetricians and gynaecologists: Suicidal thoughts and burnout rose after pandemic, survey suggests. 妇产科医生：调查显示，大流行后，自杀念头和倦怠感上升。

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1602

Kate Bowie

引用次数: 0

Our Future Health: consent, clinical risk, and industry issues plague the UK’s biggest ever health research programme 我们未来的健康：同意、临床风险和行业问题困扰着英国有史以来最大的健康研究项目

The BMJ Pub Date : 2025-07-30 DOI: 10.1136/bmj.r1579

Margaret McCartney, Deborah Cohen

{"title":"Our Future Health: consent, clinical risk, and industry issues plague the UK’s biggest ever health research programme","authors":"Margaret McCartney, Deborah Cohen","doi":"10.1136/bmj.r1579","DOIUrl":"https://doi.org/10.1136/bmj.r1579","url":null,"abstract":"The UK’s flagship health research programme promises breakthroughs, but beneath an NHS branded facade, critics are asking who really benefits from this vast database, heavily backed by industry and government. Margaret McCartney and Deborah Cohen investigate As a research programme, Our Future Health (OFH) is a runaway success—at least on paper. Described by one observer as the UK Biobank “on steroids,” OFH has become the UK’s largest ever health research programme, recruiting more than 1.5 million participants in just two years, with a goal of reaching five million.1 Its scale and ambition are praiseworthy, especially for enrolling people from ethnic minority groups and low income backgrounds—communities often overlooked in medical research. Participants are told that their data, along with access to their NHS records, will help researchers make discoveries about conditions such as dementia, cancer, and heart disease. Researchers will use only deidentified data, for purposes only for “the public good.” Participants may later be asked whether they want personal feedback from their samples, including their DNA, that could “reveal health or disease risks.” Behind the headline data, however, concerns persist. To investigate the major issues The BMJ has spoken to the programme’s chief executive, Raghib Ali, as well as its critics. The first issue is consent. Volunteers can sign up through community pharmacies, mobile units, the blood transfusion service, or an NHS branded invitation promising new insights into their blood pressure and disease risk. In exchange for personal details and blood samples they receive a £10 shopping voucher. Privacy campaigners have questioned whether participants truly understand how their genetic material will be used and whether the gift voucher could amount to undue inducement. Others warn of the risks associated with returning complex polygenic risk scores of dubious clinical utility, especially in the absence of a clear NHS plan …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Majority of global liver cancer cases "preventable," Lancet commission finds. 柳叶刀委员会发现，全球大多数肝癌病例是“可以预防的”。

The BMJ Pub Date : 2025-07-29 DOI: 10.1136/bmj.r1587

Kate Bowie

引用次数: 0

Doctors are dragged into Mexico's drug wars as cartels take over clinics. 由于贩毒集团接管了诊所，医生们被拖入了墨西哥的毒品战争。

The BMJ Pub Date : 2025-07-29 DOI: 10.1136/bmj.r1591

Luke Taylor

引用次数: 0

The BMJ最新文献